Global phase 3 OCEANIC-STROKE randomized 12,327 patients to asundexian 50 mg daily vs placebo on background antiplatelets, with follow-up to 31 months. Treatment effects were consistent across TOAST ...

Q4 2025 Management View Christopher Viehbacher, President, CEO & Director, opened by stating, "We finished the year strongly ...

Researchers conducted a cross-sectional analysis to explore the relationship between sleep disorders and rheumatoid arthritis prevalence among US adults.

Pegcetacoplan injections slowed progression of geographic atrophy but had no impact on visual acuity in a real-world setting, ...

Shareholder/Analyst Call February 5, 2026 3:30 PM ESTCompany ParticipantsRyan Watts - Co-Founder, President, CEO ...

Award-winning presentation recognizes AI-CVD-HF heart failure prediction model leveraging coronary artery calcium (CAC) scans ...

Patients diagnosed with cancer in the U.S. during the first two years of the COVID-19 pandemic had significantly lower one-year cancer survival rates, leading to an estimated 17,390 more deaths than ...

As stroke systems of care evolve, clinicians are increasingly torn between the known safety of traditional, aggressive ...

Scoliosis is an abnormal spine curvature involving the trunk. It is called idiopathic when no recognized cause exists. It ...

Since November's Budapest bedlam, he's been far and away, but Hallgrimsson is locked and loaded now on next month's World Cup playoffs. In a rare one-on-one interview, he sat down with our football ...

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.